Followers | 415 |
Posts | 34739 |
Boards Moderated | 1 |
Alias Born | 08/22/2004 |
Wednesday, August 18, 2021 9:25:46 AM
Recent VRPX News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/28/2024 08:08:45 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/18/2024 09:28:22 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/10/2024 09:08:24 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/10/2024 09:07:21 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/09/2024 09:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:45:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:30:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 08:12:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:11:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/13/2024 01:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:35:20 AM
- Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments • Business Wire • 08/13/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:26:43 PM
- Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15 • Business Wire • 08/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:26:23 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 08:30:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:31:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 11:45:16 AM
- Virpax Regains Compliance with Nasdaq Minimum Bid Price • Business Wire • 07/24/2024 11:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 10:40:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 12:00:17 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/12/2024 08:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:10:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:09:58 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM